Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31, 2024